Related Experiment Video
Updated: Aug 5, 2026

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
Identification and characterization of an antigen I/II family protein produced by group A Streptococcus
Shizhen Zhang1, Nicole M Green, Izabela Sitkiewicz
1Center for Molecular and Translational Human Infectious Diseases Research, The Methodist Hospital Research Institute, The Methodist Hospital, B154, 6565 Fannin St., Houston, TX 77030, USA.
Abstract:
Group A Streptococcus (GAS) is a gram-positive human bacterial pathogen that causes infections ranging in severity from pharyngitis to life-threatening invasive disease, such as necrotizing fasciitis. Serotype M28 strains are consistently isolated from invasive infections, particularly puerperal sepsis, a severe infection that occurs during or after childbirth. We recently sequenced the genome of a serotype M28 GAS strain and discovered a novel 37.4-kb foreign genetic element designated region of difference 2 (RD2). RD2 is similar in gene content and organization to genomic islands found in group B streptococci (GBS), the major cause of neonatal infections. RD2 encodes seven proteins with conventional gram-positive secretion signal sequences, six of which have not been characterized. Herein, we report that one of these six proteins (M28_Spy1325; Spy1325) is a member of the antigen I/II family of cell surface-anchored molecules produced by oral streptococci. PCR and DNA sequence analysis found that Spy1325 is very well conserved in GAS strains of distinct M protein serotypes. As assessed by real-time TaqMan quantitative PCR, the Spy1325 gene was expressed in vitro, and Spy1325 protein was present in culture supernatants and on the GAS cell surface. Western immunoblotting and enzyme-linked immunosorbent assays indicated that Spy1325 was produced by GAS in infected mice and humans. Importantly, the immunization of mice with recombinant Spy1325 fragments conferred protection against GAS-mediated mortality. Similar to other antigen I/II proteins, recombinant Spy1325 bound purified human salivary agglutinin glycoprotein. Spy1325 may represent a shared virulence factor among GAS, GBS, and oral streptococci.
Insights
Group A Streptococcus (GAS) invasive infections are linked to a novel genetic element, RD2. A key protein, Spy1325, found on the bacterial surface, shows potential as a shared virulence factor and vaccine target against GAS and related bacteria.
Area of Science:
- Microbiology
- Bacterial Pathogenesis
- Genomics
Background:
- Group A Streptococcus (GAS) causes diverse human infections, with M28 serotype strains frequently linked to severe invasive disease, including puerperal sepsis.
- Genomic analysis of M28 GAS revealed a novel foreign genetic element, region of difference 2 (RD2), similar to genomic islands in Group B Streptococcus (GBS).
- RD2 encodes seven proteins, including Spy1325, a newly characterized antigen I/II family protein with potential implications for inter-species virulence.
Purpose of the Study:
- To characterize the novel RD2 element and its encoded proteins in Group A Streptococcus.
- To investigate the expression, localization, and potential role of the Spy1325 protein in GAS pathogenesis.
- To evaluate Spy1325 as a potential vaccine candidate against GAS infections.
Main Methods:
- Genome sequencing of M28 GAS strain and identification of the RD2 element.
- PCR and DNA sequencing to assess Spy1325 gene conservation across GAS serotypes.
- Real-time quantitative PCR, Western immunoblotting, and ELISA to determine Spy1325 gene expression and protein presence in vitro and in vivo.
- Immunization of mice with recombinant Spy1325 fragments and assessment of protection against GAS challenge.
- Biochemical assays to analyze Spy1325 binding to human salivary agglutinin.
Main Results:
- The novel 37.4-kb RD2 element was identified in M28 GAS strains.
- The Spy1325 gene is highly conserved across different GAS serotypes and is expressed by GAS in vitro and in vivo.
- Spy1325 protein is present in culture supernatants and on the GAS cell surface, and is detected in infected hosts.
- Immunization with Spy1325 conferred protection against GAS-induced mortality in mice.
- Spy1325 demonstrated binding to human salivary agglutinin, similar to other antigen I/II proteins.
Conclusions:
- Spy1325, encoded by the novel RD2 element, is a conserved, surface-exposed protein in GAS.
- Spy1325 is a potential shared virulence factor among GAS, GBS, and oral streptococci.
- Spy1325 represents a promising vaccine candidate for preventing invasive Group A Streptococcus infections.
More Related Videos
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Protein Families
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Determinants of Bacterial Pathogenicity and Virulence
Staphylococcal Skin Infections
Streptococcal Pharyngitis

